Skip to main content
Erschienen in: Pediatric Cardiology 4/2005

01.08.2005

Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Diastolic Dysfunction in Children with Kawasaki Disease

verfasst von: S. Kurotobi, N. Kawakami, K. Shimizu, H. Aoki, S. Nasuno, K. Takahashi, S. Kogaki, K. Ozono

Erschienen in: Pediatric Cardiology | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

Although an increased level of serum brain natriuretic peptide (BNP) has been reported in children in the acute phase of Kawasaki disease (KD), no precise relation was documented between the serum BNP level and left ventricular (LV) systolic function. We hypothesized that the increased BNP levels may be explained by diastolic abnormalities in those with KD. We prospectively studied 25 patients in the acute phase of KD. Patients with abnormal systolic function were excluded. Pediatric cardiologists making the assessment of LV diastolic function were blinded to the BNP levels. Doppler interrogation was applied to measure LV inflow velocities, which were transformed to z scores using control measurements obtained from 83 healthy subjects. In the patients, the BNP levels ranged from 2.0 to 450.0 pg/ml, with a mean of 54.0 ± 102.8 pg/ml. Six patients with abnormal velocities (> 2 SD in z score) showed significantly higher levels of BNP (152 ± 173 pg/ml) than those in the remaining patients (p < 0.01). The BNP levels correlated positively with diastolic atrial velocity in z score (r = 0.51, p < 0.05), and negatively with diastolic early velocity to atrial velocity ratio in z score (r = -0.75, p < 0.01). This study suggests that LV diastolic dysfunction may occur in some children in the acute phase of KD, causing an increased level of BNP.
Literatur
1.
Zurück zum Zitat Bu’Lock, FA, Mott, MG, Martin, RP 1995Left ventricular diastolic function in children measured by Doppler echocardiography: normal values and relation with growthBr Heart J73334339PubMedCrossRef Bu’Lock, FA, Mott, MG, Martin, RP 1995Left ventricular diastolic function in children measured by Doppler echocardiography: normal values and relation with growthBr Heart J73334339PubMedCrossRef
2.
Zurück zum Zitat Harada, K, Suzuki, T, Tamura, M, et al. 1995Role of age on transmitral flow velocity patterns in assessing left ventricular diastolic function in normal infants and childrenAm J Cardiol76530532PubMedCrossRef Harada, K, Suzuki, T, Tamura, M,  et al. 1995Role of age on transmitral flow velocity patterns in assessing left ventricular diastolic function in normal infants and childrenAm J Cardiol76530532PubMedCrossRef
3.
Zurück zum Zitat Kawamura, T, Wago, M 2002Brain natriuretic peptide can be useful biochemical marker for myocarditis in patients with Kawasaki diseaseCardiol Young12153158PubMedCrossRef Kawamura, T, Wago, M 2002Brain natriuretic peptide can be useful biochemical marker for myocarditis in patients with Kawasaki diseaseCardiol Young12153158PubMedCrossRef
4.
Zurück zum Zitat Kawamura, T, Wago, M, Kawaguchi, H, Tahara, M, Yuge, M 2000Plasma brain natriuretic peptide concentrations in patients with Kawasaki diseasePediatr Int42241248PubMedCrossRef Kawamura, T, Wago, M, Kawaguchi, H, Tahara, M, Yuge, M 2000Plasma brain natriuretic peptide concentrations in patients with Kawasaki diseasePediatr Int42241248PubMedCrossRef
5.
Zurück zum Zitat Kjaer, A, Hesse, B 2001Heart failure and neuroendocrine activation: diagnostic, prognostic, and therapeutic perspectivesClin Physiol21661672PubMedCrossRef Kjaer, A, Hesse, B 2001Heart failure and neuroendocrine activation: diagnostic, prognostic, and therapeutic perspectivesClin Physiol21661672PubMedCrossRef
6.
Zurück zum Zitat Koch, A, Singer, H 2003Normal values of B type natriuretic peptides in infants, children, and adolescentsHeart89875878PubMedCrossRef Koch, A, Singer, H 2003Normal values of B type natriuretic peptides in infants, children, and adolescentsHeart89875878PubMedCrossRef
7.
Zurück zum Zitat Kohno, M, Horio, T, Yokokawa, K, et al. 1992Brain natriuretic peptide as a cardiac hormone in essential hypertensionAm J Med922934PubMedCrossRef Kohno, M, Horio, T, Yokokawa, K,  et al. 1992Brain natriuretic peptide as a cardiac hormone in essential hypertensionAm J Med922934PubMedCrossRef
8.
Zurück zum Zitat Ma, KK, Ogawa, T, Bold, AJ 2004Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by proinflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinaseJ Mol Cell Cardiol36505513PubMedCrossRef Ma, KK, Ogawa, T, Bold, AJ 2004Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by proinflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinaseJ Mol Cell Cardiol36505513PubMedCrossRef
9.
Zurück zum Zitat Maeda, K, Takayoshi, T, Wada, A, Hisanaga, T, Kinoshita, M 1998Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunctionAm Heart J135825832PubMedCrossRef Maeda, K, Takayoshi, T, Wada, A, Hisanaga, T, Kinoshita, M 1998Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunctionAm Heart J135825832PubMedCrossRef
10.
Zurück zum Zitat Matsubara, T 1991Interleukin 6 activities and tumor necrosis factor-alpha levels in serum of patients with Kawasaki diseaseArerugi40147154PubMed Matsubara, T 1991Interleukin 6 activities and tumor necrosis factor-alpha levels in serum of patients with Kawasaki diseaseArerugi40147154PubMed
11.
Zurück zum Zitat Mukoyama, M, Nakao, K, Hosoda, K, et al. 1991Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptideJ Clin Invest8714021412PubMedCrossRef Mukoyama, M, Nakao, K, Hosoda, K,  et al. 1991Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptideJ Clin Invest8714021412PubMedCrossRef
12.
Zurück zum Zitat Newburger, JW, Takahashi, M, Beiser, AS, et al. 1991A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndromeN Engl J Med32416331639PubMedCrossRef Newburger, JW, Takahashi, M, Beiser, AS,  et al. 1991A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndromeN Engl J Med32416331639PubMedCrossRef
13.
Zurück zum Zitat Quasney, MW, Bronstein, DE, Cantor, RM, et al. 2001Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki diseasePediatr Res49686690PubMedCrossRef Quasney, MW, Bronstein, DE, Cantor, RM,  et al. 2001Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki diseasePediatr Res49686690PubMedCrossRef
14.
Zurück zum Zitat Schmitz, L, Koch, H, Bein, G, Brockmeier, K 1988Left ventricular diastolic function in infants, children, and adolescents. Reference values and analysis of morphologic and physiologic determinants of echocardiographic Doppler flow signals during growth and maturationJ Am Coll Cardiol3214411448CrossRef Schmitz, L, Koch, H, Bein, G, Brockmeier, K 1988Left ventricular diastolic function in infants, children, and adolescents. Reference values and analysis of morphologic and physiologic determinants of echocardiographic Doppler flow signals during growth and maturationJ Am Coll Cardiol3214411448CrossRef
15.
Zurück zum Zitat Suzuki, H, Uemura, S, Tone, S, et al. 1996Effect of immunoglobulin and gamma-interferon on the production of tumor necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki diseaseEur J Pediatrl55291296CrossRef Suzuki, H, Uemura, S, Tone, S,  et al. 1996Effect of immunoglobulin and gamma-interferon on the production of tumor necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki diseaseEur J Pediatrl55291296CrossRef
16.
Zurück zum Zitat Yamamoto, K, Burnett, JC,Jr, Jougasaki, M, et al. 1996Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophyHypertension1996988994 Yamamoto, K, Burnett, JC,Jr, Jougasaki, M,  et al. 1996Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophyHypertension1996988994
17.
Zurück zum Zitat Yamamoto, K, Burnett, JC,Jr, Redfield, MM 1997Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heartAm J Physiol273H2406H2414PubMed Yamamoto, K, Burnett, JC,Jr, Redfield, MM 1997Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heartAm J Physiol273H2406H2414PubMed
18.
Zurück zum Zitat Yasue, H, Yoshimura, M, Sumida, H, et al. 1994Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failureCirculation90195203PubMed Yasue, H, Yoshimura, M, Sumida, H,  et al. 1994Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failureCirculation90195203PubMed
19.
Zurück zum Zitat Yoshibayashi, M, Kamiya, T, Saito, Y, et al. 1995Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birthEur J Endocrinol133207209PubMedCrossRef Yoshibayashi, M, Kamiya, T, Saito, Y,  et al. 1995Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birthEur J Endocrinol133207209PubMedCrossRef
Metadaten
Titel
Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Diastolic Dysfunction in Children with Kawasaki Disease
verfasst von
S. Kurotobi
N. Kawakami
K. Shimizu
H. Aoki
S. Nasuno
K. Takahashi
S. Kogaki
K. Ozono
Publikationsdatum
01.08.2005
Erschienen in
Pediatric Cardiology / Ausgabe 4/2005
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-004-0812-4

Weitere Artikel der Ausgabe 4/2005

Pediatric Cardiology 4/2005 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.